Skip to main content Accessibility help
×
Hostname: page-component-78c5997874-lj6df Total loading time: 0 Render date: 2024-11-20T02:46:48.117Z Has data issue: false hasContentIssue false

Chapter Seven - Injury Fields

from Part II - Constructing Injury and Imagining Remedies

Published online by Cambridge University Press:  24 February 2018

Anne Bloom
Affiliation:
University of California, Berkeley
David M. Engel
Affiliation:
State University of New York, Buffalo
Michael McCann
Affiliation:
University of Washington
Get access

Summary

Jain begins by noting that injury has always been distributed unevenly. But now, well into the twenty-first century, we can’t even point to an untouched, uninjured body capable of being recouped through the promise of a compensatory legal award in a product liability case. Living now means living in a time of injury. While American law, policy, medicine, and experimental science still valorize cause and effect as a necessary condition of regulation, how might “injury” maintain conceptual or political meaning in a post nuclear-testing, post-Monsanto, post-pension world? How might we consider injury as a field rather than as an event constituted by a clear cause and effect? In this chapter, Jain offers a case study of IVF, focusing specifically on the use of hormones and other procedures that have been used off-label or grand-fathered in rather than been fully investigated and deemed safe. Jain disentangles the various aspects of the procedure to better understand how product liability could, in theory, capture the ways in which potential injuries circulate throughout the practice. Jain offers this as a way to understand how injury operates as a field, even a recursive field.
Type
Chapter
Information
Injury and Injustice
The Cultural Politics of Harm and Redress
, pp. 154 - 184
Publisher: Cambridge University Press
Print publication year: 2018

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Ahuja, K. K. and Simons, E. G.. (1998). “Cancer of the Colon in an Egg Donor: Policy Repercussions for Donor Recruitment.” Human Reproduction 13:227–31.Google Scholar
Bandera, C. A. (2005). “Advances in the Understanding of Risk Factors for Ovarian Cancer.” Journal of Reproductive Medicine 50:399406.Google Scholar
Beatson, G. T. (1896). “On Treatment of Inoperable Cases of Carcinoma of the Mamma: Suggestions for a New Method of Treatment, with Illustrative Cases.” Paper presented to the Edinburgh Medico-Chirurgical Society, May 20, 1896. Lancet 2:104–7.Google Scholar
Becker, G. (2000). Elusive Embryo: How Women and Men Approach New Reproductive Technologies. Berkeley, CA: University of California Press.CrossRefGoogle Scholar
Bell, S. (2009). DES Daughters, Embodied Knowledge, and the Transformation of Women's Health Politics in the Late Twentieth Century. Philadelphia, PA: Temple University Press.Google Scholar
Berger, J. (1999). “Our Towns: Yale Gene Pool Seen as Route to Better Baby.” New York Times, January 10.Google Scholar
Blackwell, T. (2011). “In-Vitro Fertilization Linked to Rare Genetic Disorders.” National Post, September 25.Google Scholar
Bleyer, A. (2011). “Latest Estimates of Survival Rates of the 24 Most Common Cancers in Adolescent and Young Adult Americans.” Journal of Adolescent and Young Adult Oncology 1(1):3742.Google Scholar
Brinton, L. (2007). “Long-Term Effects of Ovulation-Stimulating Drugs on Cancer Risk.” Reproductive BioMedicine Online 15.Google ScholarPubMed
Calderon-Margalit, R. et al. (2009). “Cancer Risk after Exposure to Treatments for Ovulation Induction.” American Journal of Epidemiology 169:365–75.Google Scholar
CDC. (2014). “ART Success Rates.” www.cdc.gov/art/artdata/index.html [cited as CDC 2014].Google Scholar
Chlebowski, R. T. et al. (2010). “Estrogen Plus Progestin and Breast Cancer Incidence and Mortality in Postmenopausal Women.” JAMA 304:1684–92.Google Scholar
Coeytaux, F. (2005). Testimony on Egg Retrieval to California Senate Committee, Joint Oversight Hearing on the Implementation of Proposition 71, the Stem Cell Research and Cures Act, March 9. www.geneticsandsociety.org/article.php?id=180.Google Scholar
Collaborative Group on Hormone Factors in Breast Cancer. (1996). “Breast Cancer and Hormonal Contraceptives: Collaborative Reanalysis of Individual Data on 53,297 Women with Breast Cancer and 100,239 Women without Breast Cancer for 54 Epidemiological Studies.” Lancet 347:1713–27.Google Scholar
Correspondence: Risk of Ovarian Cancer after Treatment for Infertility.” (1995). New England Journal of Medicine 332:1300–2 [cited as Correspondence 1995].Google Scholar
Cramer, D., Hartge, W. P., Nasca, P. C., and Whittemore, A. S.. (1995). “Letter to the editor.” New England Journal of Medicine 332:1300–2.Google Scholar
Davis, D. S. (2006). “The Puzzle of IVF.” Houston Journal of Health Law and Policy 6: 275.Google Scholar
Dor, J., Lerner-Geva, L., Rabinovici, J. et al. (1996). “Cancer Incidence in a Cohort of Infertile Women Treated with In Vitro Fertilization.” 52nd Annual Meeting of the American Society for Reproductive Medicine suppl., 147.Google Scholar
Dumit, J. (2012). Drugs for Life. Durham, NC: Duke University Press.Google Scholar
Edwards, R. C. (2007). “IVF, IVM, Natural Cycle IVF, Minimal Stimulation IVF – Time for a Rethink.” Reproductive Medicine Online 15:106219.CrossRefGoogle ScholarPubMed
Ethics Committee of the American Society for Reproductive Medicine. (2007). “Financial Compensation of Oocyte Donors.” Fertility and Sterility 88 [cited as Ethics Committee 2007].Google Scholar
Family Issue Fact Sheet No. 2010–03 (March 2010), S.B. 1306/H.B. 2651 – Human Egg Provider Protection Act, Center for Arizona Policy [cited as Family Fact Sheet 2010].Google Scholar
FDA. (2017). “Information and Recommendations for Physicians Involved in the Co-Culture of Human Embryos with Non-Human Animal Cells.” www.fda.gov/BiologicsBloodVaccines/Xenotransplantation/ucm136532.htmGoogle Scholar
Giudice, L., Santa, E., and Pool, R., eds. (2007). Assessing the Medical Risks of Human Oocyte Donation for Stem Cell Research: Workshop Report. Washington, DC: National Academic Press.Google Scholar
Hamilton, J. (2000). “What Are the Costs?Stanford Magazine, November–December.Google Scholar
Holzer, H. et al. (2007). “In Vitro Maturation of Oocytes Collected from Unstimulated Ovaries for Oocyte Donation.” Fertility and Sterility 88:62–7.Google Scholar
Jain, L. (2004). “Dangerous Instrumentality (Bystander as Subject in Automobility).” Cultural Anthropology 19(1):6194.Google Scholar
Jain, L. (2006). Injury: The Politics of Product Design and Safety Law in the United States. Princeton, NJ: Princeton University Press.Google Scholar
Jain, L. (2013). Malignant: How Cancer Becomes Us. Berkeley, CA: University of California Press.Google Scholar
Jordan-Young, R. (2010). Brain Storm: The Flaws in the Science of Sex Differences. Cambridge, MA: Harvard University Press.Google Scholar
Kaufman, S. R., Russ, A. J., and Shim, J. K.. (2006). “Aged Bodies and Kinship Matters: The Ethical Field of Kidney Transplant.” American Ethnologist 33:81–9.CrossRefGoogle ScholarPubMed
Kennard, E. A. et al. (1989). “A Program for Matched, Anonymous, Oocyte Donation.” Fertility and Sterility 51:655–60.CrossRefGoogle ScholarPubMed
Kirschner, M. et al. (2000). “Molecular Vitalism.” Cell 100:86.Google Scholar
Kramer, W., Schneider, J., and Schultz, N.. (2009). “U.S. Oocyte Donors: A Retrospective Study of Medical and Psychosocial Issues.” Human Reproduction 24:3144–9.CrossRefGoogle ScholarPubMed
Lahl, J. (2009). Eggsploitation: The Infertility Industry Has a Dirty Little Secret, a film by the Center for Bioethics and Culture, dir. Jennifer Lahl (Lines that Divide).Google Scholar
Langston, N. (2010). Toxic Bodies: Hormone Disruptors and the Legacy of DES. New Haven, CT: Yale University Press.Google Scholar
van Leeuwen, F. E., Klip, H., Mooij, T. M., et al. (2011). “Risk of Borderline and Invasive Ovarian Tumours after Ovarian Stimulation for In Vitro Fertilization in a Large Dutch Cohort.” Human Reproduction, October 26, 3456–65. http://humrep.oxfordjournals.org/content/early/2011/10/19/humrep.der322.full.Google Scholar
Levine, A. (2010). “Self-Regulation, Compensation, and the Ethical Recruitment of Oocyte Donors.” Hastings Center Report, March–April:2536.CrossRefGoogle ScholarPubMed
Lew, K. (2010). Egg Donation: The Reasons and the Risks. New York: Rosen Publishing.Google Scholar
Lutjen, P. et al. (1984). “The Establishment and Maintenance of Pregnancy Using In Vitro Fertilization and Embryo Donation in a Patient with Primary Ovarian Failure.” Nature 307(1984):174–5.Google Scholar
Magnus, D. and Cho, M. K.. (2006). “A Commentary on Oocyte Donation for Stem Cell Research in South Korea.” American Journal of Bioethics 6:W234.Google Scholar
Mathias, R. J. and Clench, M. H.. (1995). “Placebo Controlled Study Randomizing Leuprolide Acetate.” Digestive Diseases and Sciences 40:1405.Google Scholar
Maxwell, K. N., Cholst, I. N., and Rosenwaks, Z.. (2008). “The Incidence of Both Serious and Minor Complications in Young Women Undergoing Oocyte Donation.” Fertility and Sterility 90:2165.CrossRefGoogle ScholarPubMed
Murphy, M. (2017). Alterlife in the Aftermath of Environmental Violence, talk given at UCSF, February 8, 2017.Google Scholar
Millican, L. (2003). “Testimony before the Subcommittee of Science, Technology, and Space, Committee on Commerce, Science, and Transportation.” U.S. Senate, March 27.Google Scholar
Mosgaard, B. J., Lidegaard, O., Kjaer, S. K., et al. (1998). “Ovarian Stimulation and Borderline Ovarian Tumours: A Case–Control Study.” Fertility and Sterility 70:1049–55.CrossRefGoogle ScholarPubMed
Mukherjee, S. (2010). The Emperor of All Maladies: A Biography of Cancer. New York: Scribner.Google Scholar
Myers, J. P. and vom Saal, F. S.. (2008). “Time to Update Environmental Regulations: Should Public Health Standards for Endocrine-Disrupting Compounds Be Based upon Sixteenth-Century Dogma or Modern Endocrinology?San Francisco Medicine 81:30–1.Google Scholar
Nader, R. (1965). Unsafe at Any Speed. New York: Richard L. Grossman.Google Scholar
National Cancer Institute. (2013) “Adolescents and Young Adults with Cancer.” www.cancer.gov/cancertopics/aya/types/quiz.Google Scholar
Norsigian, J. (2005). “Egg Donation Dangers.” GeneWatch 18(5):68, 16.Google ScholarPubMed
Oudshoorn, N. (1994). Beyond the Natural Body: An Archaeology of Sex Hormones. New York: Routledge.Google Scholar
Pappo, I., et al. (2008). “Possible Association between IVF and Breast Cancer Incidence.” Annals of Surgical Oncology 15:1048–55.Google Scholar
Pearson, H. (2006). “Special Report: Health Effects of Egg Donation May Take Decades to Emerge.” Nature 442:607–8.Google Scholar
Powdthavee, N. (2009). ‘Think Having Children Will Make You Happy?Psychologist 22:308–10.Google Scholar
“Prempro Settlement Reached in Lawsuit over HRT Breast Cancer.” (2010). AboutLawsuits.org, August 31. www.aboutlawsuits.com/prempro-settlement-reached-lawsuit-breast-cancer-12483 [cited as Prempro Settlement 2010].Google Scholar
Roberts, E. (2011). “Abandonment and Accumulation: Embryonic Futures in the United States and Ecuador.” Medical Anthropology Quarterly 25:232–53.Google Scholar
Rossing, M. A., Daling, J. R., Weisset, N. S., et al. (1994). “Ovarian Tumors in a Cohort of Infertile Women.” New England Journal of Medicine 331:771–6.Google Scholar
Russo, J., Moral, R., Balogh, G. A., et al. (2005). “The Protective Role of Pregnancy in Breast Cancer.” Breast Cancer Research 7:131–42.CrossRefGoogle ScholarPubMed
Sauer, M. V., Paulson, R. J., and Lobo, R. A. (1996). “Rare Occurrence of Ovarian Hyperstimulation Syndrome in Oocyte Donors.” International Journal of Gynecology and Obstetrics 52:259–62.Google Scholar
Schneider, J. (2007). “It's Time for an Egg Donor Registry and Long-Term Follow-Up.” Testimony at Congressional Briefing on Human Egg Trafficking, November 14.Google Scholar
Seaman, A. M. (2012). “IVF in Young Women Tied to Later Breast Cancer.” Reuters, June 23. www.reuters.com/article/2012/06/22/us-ivf-breast-cancer-idUSBRE85L1DM20120622.Google Scholar
Shenfield, F. (1996). “Cancer Risk and Fertility Treatments: A Question of Informed Consent.” Journal of Fertility Counseling 1516.Google Scholar
Shepard, T. H., ed. (1992). Catalogue of Teratogenic Agents, 7th edn, Baltimore, MD: Johns Hopkins University Press.Google Scholar
Silver-Greenbert, J. (2012). “In Vitro a Fertile Niche for Lenders.” Wall Street Journal, February 24.Google Scholar
Skoch, I. (2010). “Should IVF Be Affordable for All?News Week, July 21.Google Scholar
Sprague, B. L., et al. (2011). “The Contribution of Postmenopausal Hormone Use Cessation to the Declining Incidence of Breast Cancer.” Cancer Causes and Control 22:125–34.Google Scholar
Stewart, L. K. et al. (2012). “In Vitro Fertilization and Breast Cancer: Is There Cause for Worry?Fertility and Sterility 98:334–40.Google Scholar
Uroz, V. and Guerra, L.. (2009). “Donation of Eggs in Assisted Reproduction and Informed Consent.” Medicine and Law 28:565–75.Google Scholar
Watkins, E. (2007). The Estrogen Elixir: A History of Hormone Replacement Therapy in America. Baltimore, MD: Johns Hopkins University Press.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure [email protected] is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×